Drug Type ASO |
Synonyms |
Target |
Mechanism TDP43 modulators(TAR DNA binding protein 43 modulators) |
Active Indication- |
Inactive Indication |
Originator Organization QurAlis Corp.Startup |
Active Organization- |
Inactive Organization QurAlis Corp.Startup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | US | QurAlis Corp.Startup | 19 Jul 2022 |
Frontotemporal Dementia | Preclinical | US | QurAlis Corp.Startup | 19 Jul 2022 |